BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1516633)

  • 1. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone.
    McAdam AJ; Blieden TM; Frelinger JG; Lord EM
    Eur J Immunol; 1992 Sep; 22(9):2461-4. PubMed ID: 1516633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex.
    Fleury SG; Croteau G; Sékaly RP
    Semin Immunol; 1991 May; 3(3):177-85. PubMed ID: 1909595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Existence of mature human CD4+ T cells with genuine class I restriction.
    De Bueger M; Bakker A; Goulmy E
    Eur J Immunol; 1992 Mar; 22(3):875-8. PubMed ID: 1372262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a role for TNF-alpha in cytolysis by CD4+, class II MHC-restricted cytotoxic T cells.
    Tite JP
    Immunology; 1990 Oct; 71(2):208-12. PubMed ID: 2228021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of intraepithelial lymphocytes from major histocompatibility complex (MHC)-deficient mice: no evidence for a role of MHC class II antigens in the positive selection of V delta 4+ gamma delta T cells.
    Schleussner C; Ceredig R
    Eur J Immunol; 1993 Jul; 23(7):1615-22. PubMed ID: 8391987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T helper cell response is required for memory in CD8+ T lymphocytes induced by a poly(I:C)-adjuvanted MHC I-restricted peptide epitope.
    Qiu F; Cui Z
    J Immunother; 2007; 30(2):180-9. PubMed ID: 17471165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
    McKisic MD; Sant AJ; Fitch FW
    J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
    van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
    J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice.
    Marusić-Galesić S; Udaka K; Walden P
    Eur J Immunol; 1993 Dec; 23(12):3115-9. PubMed ID: 8258325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC.
    Grogg D; Hahn S; Erb P
    Eur J Immunol; 1992 Jan; 22(1):267-72. PubMed ID: 1346113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a CD4(L3T4)-positive cytotoxic T cell clone that is restricted by class I major histocompatibility complex antigen on FBL-3 tumor cell.
    Matsubayashi Y; Zenita K; Morioka A; Iwashiro M; Masuda T; Uchino H; Fujita T; Kuribayashi K
    Immunobiology; 1989 Nov; 180(1):33-46. PubMed ID: 2483152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.